Global, regional, and national quality of care of ischaemic heart disease from 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017.

AIMS By 2030, we seek to reduce premature deaths from non-communicable diseases, including ischaemic heart disease (IHD), by one-third to reach the sustainable development goal (SDG) target 3.4. We aimed to investigate the quality of care of IHD across countries, genders, age groups, and time using the Global Burden of Diseases Study (GBD) 2017 estimates. METHODS AND RESULTS We did a principal component analysis on IHD mortality to incidence ratio, disability-adjusted life-years (DALYs) to prevalence ratio, and years of life lost to years lived with disability ratio using the results of the GBD 2017. The first principal component was scaled from 0 to 100 and designated as the quality of care index (QCI). We evaluated gender inequity by the gender disparity ratio (GDR), defined as female to male QCI. From 1990 to 2017, the QCI and GDR increased from 71.2 to 76.4 and from 1.04 to 1.08, respectively, worldwide. In the study period, countries of Western Europe, Scandinavia, and Australasia had the highest QCIs and a GDR of 1 to 1.2; however, African and South Asian countries had the lowest QCIs and a GDR of 0.8 to 1. Moreover, the young population experienced more significant improvements in the QCI compared to the elderly in 2017. CONCLUSION From 1990 to 2017, the QCI of IHD has improved; nonetheless, there are remarkable disparities between countries, genders, and age groups that should be addressed. These findings may guide policymakers in monitoring and modifying our path to achieve SDGs.

[1]  F. Farzadfar,et al.  A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic analysis 1990-2017 , 2021, PloS one.

[2]  F. Farzadfar,et al.  A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017 , 2021, Experimental Hematology & Oncology.

[3]  F. Farzadfar,et al.  Quality of Care Index (QCI) v1 , 2020 .

[4]  D. van Klaveren,et al.  Sex Differences in All-Cause Mortality in the Decade Following Complex Coronary Revascularization. , 2020, Journal of the American College of Cardiology.

[5]  M. Naghavi,et al.  Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990-2017. , 2020, European journal of preventive cardiology.

[6]  R. Kornowski,et al.  Current Status of Cardiovascular Medicine in Israel. , 2020, Circulation.

[7]  K. Christensen,et al.  Do men avoid seeking medical advice? A register-based analysis of gender-specific changes in primary healthcare use after first hospitalisation at ages 60+ in Denmark , 2020, Journal of Epidemiology & Community Health.

[8]  P. Amouyel,et al.  Coronary heart disease incidence still decreased between 2006 and 2014 in France, except in young age groups: Results from the French MONICA registries , 2020, European journal of preventive cardiology.

[9]  S. Capewell,et al.  Explaining the decline in coronary heart disease mortality rates in Japan: Contributions of changes in risk factors and evidence-based treatments between 1980 and 2012. , 2019, International journal of cardiology.

[10]  J. Stehli,et al.  Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention , 2019, Journal of the American Heart Association.

[11]  Haniye Sadat Sajadi,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[12]  Haniye Sadat Sajadi,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[13]  Reza Ghadimi Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, Lancet.

[14]  S. Harikrishnan,et al.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. , 2018, Lancet.

[15]  Ronan A Lyons,et al.  Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 , 2018, The Lancet.

[16]  B. Lindahl,et al.  Sex Differences in Treatments, Relative Survival, and Excess Mortality Following Acute Myocardial Infarction: National Cohort Study Using the SWEDEHEART Registry , 2017, Journal of the American Heart Association.

[17]  Alan D. Lopez,et al.  Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 , 2017, Journal of the American College of Cardiology.

[18]  S. Halvorsen,et al.  Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study , 2017, BMC Cardiovascular Disorders.

[19]  H. Bueno,et al.  Management of Acute Coronary Syndromes in Geriatric Patients. , 2017, Heart, lung & circulation.

[20]  W. Qiu,et al.  Gender Differences in Outcomes and Predictors of All-Cause Mortality After Percutaneous Coronary Intervention (Data from United Kingdom and Sweden). , 2017, The American journal of cardiology.

[21]  M. Visser,et al.  Explaining the Decline in Coronary Heart Disease Mortality in the Netherlands between 1997 and 2007 , 2016, PloS one.

[22]  L. Badimón,et al.  DELAY TO HOSPITAL ADMISSION AND ACUTE CORONARY CARE IN THE ELDERLY AND IN THE VERY ELDERLY , 2016 .

[23]  A. E. Thompson,et al.  The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study , 2016, BMC Family Practice.

[24]  M. Gulati,et al.  Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[25]  Deepak L. Bhatt,et al.  Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States. , 2015, Journal of the American College of Cardiology.

[26]  H. Nathoe,et al.  Worse outcome in women with STEMI: a systematic review of prognostic studies , 2015, European journal of clinical investigation.

[27]  L. Cheskin,et al.  Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis. , 2014, JAMA internal medicine.

[28]  G. Fonarow,et al.  International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries☆☆☆ , 2014, International journal of cardiology.

[29]  C. Gale,et al.  Acute coronary syndrome management in older adults: guidelines, temporal changes and challenges. , 2014, Age and ageing.

[30]  P. Heuschmann,et al.  Supplementary Appendix , 2013 .

[31]  Deepak L. Bhatt,et al.  Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. , 2012, The American journal of medicine.

[32]  L. Chambless,et al.  The effect of revascularization procedures on myocardial infarction incidence rates and time trends: the MONICA-Brianza and CAMUNI MI registries in Northern Italy. , 2012, Annals of epidemiology.

[33]  L. Kiemeney,et al.  The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. , 2011, European journal of public health.

[34]  J. Mckinlay,et al.  Disparities in physicians' interpretations of heart disease symptoms by patient gender: results of a video vignette factorial experiment. , 2009, Journal of women's health.

[35]  W. Rogers,et al.  Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. , 2008, American heart journal.

[36]  M. Naylor,et al.  Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. , 2007, Circulation.

[37]  M. Naylor,et al.  Acute Coronary Care in the Elderly, Part II: ST-Segment–Elevation Myocardial Infarction A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology , 2007, Circulation.

[38]  Deepak L. Bhatt,et al.  Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative , 2004 .

[39]  M. Flather,et al.  The management and investigation of elderly patients with acute coronary syndromes without ST elevation: an evidence-based approach? Results of the Prospective Registry of Acute Ischaemic Syndromes in the United Kingdom (PRAIS-UK). , 2005, Age and ageing.